Академический Документы
Профессиональный Документы
Культура Документы
Markets Research
North America
United States
Quantitative Strategy
Date
4 March 2014
Sheng Wang
sheng.wang@db.com
Miguel-A Alvarez
miguel-a.alvarez@db.com
Javed Jussa
javed.jussa@db.com
Zongye Chen
john.chen@db.com
Allen Wang
allen-y.wang@db.com
Yin Luo, CFA
yin.luo@db.com
North America: +1 212 250 8983
Europe: +44 20 754 71684
Asia: +852 2203 6990
________________________________________________________________________________________________________________
Deutsche Bank Securities Inc.
Note to U.S. investors: US regulators have not approved most foreign listed stock index futures and options for US
investors. Eligible investors may be able to get exposure through over-the-counter products. Deutsche Bank does and
seeks to do business with companies covered in its research reports. Thus, investors should be aware that the firm may
have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a
single factor in making their investment decision. DISCLOSURES AND ANALYST CERTIFICATIONS ARE LOCATED IN
APPENDIX 1.MICA(P) 054/04/2013.
4 March 2014
The Quant View
Crowdsourcing earnings
estimates
Introducing the Estimize dataset
Earnings estimates are one of the most widely used financial metrics. They are a
measure of expected company performance and play an important role in many equity
investors stock selection strategies. Traditionally, earnings estimates are gathered from
sell-side analysts at institutional brokers and independent research firms. Data vendors
such as Institutional Brokers Estimate System (IBES) aggregate these estimates and
offer daily or monthly updates as well as historical datasets. While there are many data
vendors that aggregate sell-side earnings estimates, we have yet to find a reputable
database that collects estimates from buy-side analysts and other types of investors.
In this report, we analyze a new database from the crowdsourced community Estimize
that collects earnings and revenue forecasts from various different types of investors. It
was established in 2011 and has grown rapidly to cover more than 900 US stocks.
What sets it apart is that the community of contributors is varied, ranging across buyside investment professions, individual traders, independent researchers and students.
Figure 1 shows the types of the contributors to the database.
Figure 1: Constituents of the contributors of Estimize
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
Page 2
4 March 2014
The Quant View
100%
80%
60%
40%
20%
0%
1 day
1 week
1 month
1 quarter
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
Whos contributing?
Figure 3 shows that more than two-thirds of the estimates are collected from non
financial professionals. Among the financial professionals, half are independent
researchers and the other half are split evenly between buy-side and sell-side analysts.
The sample data shows that the data covers a diverse range of investors and the
information should be complementary to the traditional institutional data sources such as
IBES.
Page 3
4 March 2014
The Quant View
Financial Professional
Non Professional
30%
26%
48%
26%
70%
independent research
buy side
sell side
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
Unfortunately, as is the case with many of the newer and unique data sources, the
history of the Estimize dataset is relatively short and coverage is less extensive than
that of traditional sell-side estimate databases such as IBES.
In this report, we focus in most part on the EPS estimates from Estimize and begin our
analysis in 2012 since much of the data prior to that is too sparse.
Figure 4 shows the number of stocks covered in the Estimize database that are
members of the Russell 3000 universe. Coverage is defined by the number of unique
tickers which have at least one estimate on some day in a current fiscal quarter during
that month; regardless of whether or not the company reports during that month.
We find a strong seasonal component in the data due to earnings seasons and the fact
that most estimates are not contributed until one week before the actual announcement
(Figure 2). In addition, stock coverage drops quickly as we increase the number of
required contributors.
Page 4
4 March 2014
The Quant View
1200
1000
800
>= 1 analyst
>= 3 analysts
>= 10 analysts
600
400
200
0
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
Figure 5 shows the median, 25th percentile, and 75th percentile of the market cap
covered by Estimize over time. The coverage consists mainly of large and midcap US
stocks and the distribution of market cap shows to be steady over the sample.
Figure 6 shows the median market cap of the stocks covered by Estimize across
different numbers of contributor (analyst) coverage. As expected, we find that larger
cap stocks which demand more attention are covered by a larger number of
contributors. This is consistent with the traditional institutional databases in that larger
cap companies will have more analyst coverage.
Figure 6: Median Market Cap of stocks covered by
Billion)
40
16
35
14
30
25
20
15
10
5
0
12
10
8
6
4
2
0
25th percentile
Median
75th percentile
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
>= 1 analyst
>= 3 analysts
>= 10 analysts
>= 20 analysts
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
Page 5
4 March 2014
The Quant View
43%
>=20 analysts
39%
57%
37%
35%
61%
63%
65%
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
However, the greater accuracy of Estimize database is in most part due to its timely
updating. Recall that most Estimize estimates are entered a few days prior to the
earnings announcement (Figure 2), while most IBES estimates are entered several
weeks in advance. For a more apples-to-apples comparison, we compare the estimates
at different horizons.
Figure 8 shows the accuracy of the average estimates at various windows before the
announcement date. The results show that one week before announcement the
accuracy across Estimize and IBES is similar. However, when looking at a one-month
window, IBES estimates tend to be more accurate than those in Estimize. This suggest
that sell-side analysts do a better job at predicting earnings over a longer window while
the more timely Estimize data tends to be more accurate within one week of the
announcement.
Page 6
4 March 2014
The Quant View
43%
1 month before
57%
46%
54%
49%
46%
51%
54%
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
49%
47%
51%
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
53%
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
Page 7
4 March 2014
The Quant View
44%
49%
56%
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
51%
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
Figure 13 further compares the difference between Estimize sell side and the IBES sell
side. The results show that IBES sell-side estimates are more accurate than those from
Estimize, which lends some credence to our hypothesis that Estimize sell-side data may
have a level of selection bias. In Figure 14, the performance for IBES sell side compared
with buy side estimates are similar as the sell side compared with buy side in Figure 11.
This is as we expected, since IBES are mostly sell side analysts estimates, so they
should have some similarity with the sell side estimates from Estimize.
Figure 13: IBES compared with sell side from Estimize
IBES more accurate
42%
46%
54%
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
58%
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
Page 8
4 March 2014
The Quant View
To analyze the post earnings drift in both the IBES and Estimize datasets we use an
event study. The day one return of the post earnings announcement is calculated using
the open to close price if the earnings was announce before the market opens; and use
next day open to close if the earnings was announce after the market close. The
following days returns are all calculated using close to close price returns. The S&P
500 total return index is used as the market return
Figure 15 and Figure 16 show the average excess return to the market for earnings
surprises greater than 10% for both Estimize and IBES estimates. In both cases the
more timely Estimize estimates shows bigger post announcement drift for both beats
and misses. However, in both cases, the cumulative excess return flattens out quickly
after the a few days, due to market efficiency.
Figure 15: Cumulative excess return when estimates beat
0.6%
0.5%
0.4%
0.3%
0.2%
0.1%
0.0%
day 0
days 2
days 3
days_4
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
days 5
0.7%
days 1
days 2
-0.1%
days 3
days_4
days 5
-0.2%
-0.3%
-0.4%
-0.5%
-0.6%
-0.7%
-0.8%
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
Page 9
4 March 2014
The Quant View
Figure 17: Wealth curve for different transaction cost of the Estimize earnings surprise strategy
5.0
4.5
4.0
5 bps
10 bps
15 bps
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
We compared the same strategy based on the same earnings surprise measure using
the IBES estimates. Figure 18 show the annualized returns and Figure 19 shows the
Sharpe ratio of the two strategies under different transaction costs. For both strategies,
the performance decreases quickly as transaction costs increase. When transaction
cost increases to 10 bps per trade, the performance of the IBES earning surprise
strategy is nearly zero, and it turns negative once we have t-costs increased to 15bps.
In contrast, the Estimize earnings surprise strategy, shows an annualized return of 12%
under the 15bps t-cost scenario.
Page 10
4 March 2014
The Quant View
120%
Estimize
100%
IBES
Estimize
2.0
IBES
1.5
80%
Sharpe ratio
Annualized return
140%
60%
40%
20%
1.0
0.5
0.0
0%
-0.5
-20%
-40%
-1.0
5 bps
10 bps
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
15 bps
5 bps
10 bps
15 bps
Source: Estimize, Compustat, IBES, Russell, S&P, Thomson Reuters, Deutsche Bank
In conclusion we found multiple benefits to using the Estimize dataset; especially in the
case of short-term applications in which accuracy is essential. Another interesting
byproduct of the analysis was the power of crowdsourcing. We found that some of the
value-added in the Estimize dataset was due to the wisdom of crowds effect as more
predictions give way to greater accuracy. Moreover, the diversity of the contributors
provides a greater spectrum of information which can potentially improve investment
strategies based on estimates.
We should also be aware of the potential issues with the Estimize dataset. The main
issue rests on the thin coverage and the short-term nature of the forecasts; especially
when compared to commonly used sell-side estimates data. Also, the short history will
pose a problem when trying to analyze the data across different market and economic
environments.
Please contact us DBEQS.Americas@db.com for more details of the Estimize dataset.
Page 11
4 March 2014
The Quant View
Macro update
Turning our attention to the bigger picture, we also take the opportunity to update our
favorite top-down market indicators.
Our favorite market timing indicator
Our Variance Risk Premium (VRP) indicator is a contrarian indicator that measures
market overreaction and underreaction to realized risk. In simple terms, VRP is the
difference between options-implied risk (i.e. the VIX index) and realized risk (i.e. the
actual risk in the market measured historically over the last month). If VRP is high, we
see this as a buying opportunity for risky assets, like equities and high yield bonds.
Why? The intuition is as follows. When VRP is high, VIX has typically shot up
dramatically (i.e. the market is in panic mode). At the same time, realized risk has
probably also risen, but not to the same extent. In other words, the market has
overreacted relative to what the actual, realized data is telling us. Our research shows
that such episodes are good buying opportunities for risky assets on about a three
month horizon. On the other hand, when VRP is low, it tends to be a complacency
indicator: investors are failing to price in rising realized risk in the market, and as a
result we should be selling risky assets like equities.
Our Variance Risk Premium (VRP) indicator is a contrarian indicator that measures
market overreaction and underreaction to realized risk. Today our VRP indicator is
reading 9.1, compared to a long-term average of 14.2. Generally we pay attention to the
VRP when it hits extreme levels (like +/- 2 standard deviations).
Figure 21: Recent VRP (lagged) and market returns
150
100
0
-50
-100
-150
-200
VRP
100
80
60
40
20
0
-20
-40
-60
Feb-14
Apr-11
-250
Sep-12
Nov-09
Jan-07
Jun-08
Aug-05
Oct-02
Mar-04
May-01
Jul-98
Dec-99
Feb-97
Apr-94
Sep-95
Nov-92
Jan-90
VRP
50
12%
10%
8%
6%
4%
2%
0%
-2%
-4%
-6%
-8%
-10%
VRP
200
2000
1800
1600
1400
1200
1000
800
600
400
200
0
Jun-91
S&P 500
Page 12
4 March 2014
The Quant View
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Stock-Specific
Global
Style
Industry
Country
Currency
Stock-Specific
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
EM Global
Style
Industry
Country
Currency
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
The key result is the size of the blue portion relative to the other colors. The blue
represents the opportunity explained by stock selection, whereas we can think of the
other colors as representing the opportunity from top-down calls like picking the right
countries, industries, and styles. When the financial crisis exploded in 2008, we moved
into a much more macro-dominated world. As a result, the portion of overall
opportunity that could be explained by individual company characteristics (e.g.
valuation, growth profile, earnings quality, etc.) shrunk sharply; no one cared if a stock
looked good on fundamentals if it was exposed to Europe for example. Needless to say,
such an environment was challenging for quants and non-quants alike, since both
camps tend to use stock specific information to differentiate between stocks.
The small cap opportunity set
We think of the opportunity set as the total available alpha on the table. Our main
interest is to understand what is driving that opportunity, because this can allow us to
position our strategies to pick in the orchard with the juiciest fruit. In Figure 24 we
show the opportunity set for the large cap universe, and in Figure 25 we show the
opportunity set for the small cap universe.
Figure 24: Large cap opportunity set
80%
60%
40%
20%
0%
80%
60%
Stock selection
opportunity set is
greater for small
cap stocks
40%
20%
Stock-Specific
Style
Industry
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Stock-Specific
Style
Feb-14
Feb-13
Feb-12
Feb-11
Feb-10
Feb-09
Feb-08
Feb-07
Feb-06
Feb-05
Feb-04
Feb-03
Feb-02
Feb-01
Feb-14
Feb-13
Feb-12
Feb-11
Feb-10
Feb-09
Feb-08
Feb-07
Feb-06
Feb-05
Feb-04
Feb-03
Feb-02
Feb-01
Feb-00
0%
Feb-00
100%
Industry
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Both charts actually tell a similar story. The key result is the size of the blue portion
relative to the other colors. The blue represents the opportunity explained by stock
selection, whereas we can think of the other colors as representing the opportunity
from top-down calls like picking industries and styles. When the financial crisis
exploded in 2008, we moved into a much more macro-dominated world. As a result,
Deutsche Bank Securities Inc.
Page 13
4 March 2014
The Quant View
Valuation spreads
Similar to the opportunity set, valuation spreads allow investors to gauge the level of
stock selection opportunity in the market. Widening valuation spreads typically indicate
more stock-level differentiation and therefore a better environment for stock selection.
On the other hand, narrowing valuation spreads are indicative of lower levels of stock
differentiation. Figure 26 and Figure 27 show the median, 25th percentile, and 75th
percentile of trailing price to earnings for the Russell 1000 and 2000 index constituents.
Interestingly, we see that valuation spreads are wider on a more consistent basis for
small cap stocks. This reinforces the earlier evidence we saw in the opportunity set; the
small cap space is rich with opportunity for skilled stock pickers.
Figure 26: Large cap valuation spreads
45x
40x
35x
30x
25x
20x
15x
10x
50x
45x
40x
35x
30x
25x
20x
15x
10x
5x
5x
25th Percentile
Median
75th Percentile
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
25th Percentile
Median
75th Percentile
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
4 March 2014
The Quant View
70%
60%
Pairwise Correlation
50%
Median pairwise
correlations tend to
be higher
40%
30%
20%
10%
50%
30%
20%
10%
-10%
25th Percentile
Median
75th Percentile
Jan-90
Jan-91
Jan-92
Jan-93
Jan-94
Jan-95
Jan-96
Jan-97
Jan-98
Jan-99
Jan-00
Jan-01
Jan-02
Jan-03
Jan-04
Jan-05
Jan-06
Jan-07
Jan-08
Jan-09
Jan-10
Jan-11
Jan-12
Jan-13
Jan-14
0%
-10%
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Median pairwise
correlations tend
to be lower
40%
0%
Jan-90
Jan-91
Jan-92
Jan-93
Jan-94
Jan-95
Jan-96
Jan-97
Jan-98
Jan-99
Jan-00
Jan-01
Jan-02
Jan-03
Jan-04
Jan-05
Jan-06
Jan-07
Jan-08
Jan-09
Jan-10
Jan-11
Jan-12
Jan-13
Jan-14
Pairwise Correlation
60%
25th Percentile
Median
75th Percentile
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Page 15
4 March 2014
The Quant View
1.05
1.10
1.05
1.00
1.00
0.95
0.95
0.90
0.90
0.85
0.85
0.80
31-Dec 5-Jan 10-Jan 15-Jan 20-Jan 25-Jan 30-Jan 4-Feb 9-Feb 14-Feb 19-Feb 24-Feb
Dividend Yield
1M Reversal
Low Volatility
Earnings Yield
EPS Growth
3M Earnings Revisions
12M-1M Momentum
ROE
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Page 16
0.80
31-Dec 5-Jan 10-Jan 15-Jan 20-Jan 25-Jan 30-Jan 4-Feb 9-Feb 14-Feb 19-Feb 24-Feb
Dividend Yield
1M Reversal
Low Volatility
Earnings Yield
EPS Growth
3M Earnings Revisions
12M-1M Momentum
ROE
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
4 March 2014
The Quant View
1.15
1.10
1.10
1.05
1.05
1.00
1.00
0.95
0.95
0.90
0.90
0.85
0.85
0.80
0.80
31-Dec 5-Jan 10-Jan 15-Jan 20-Jan 25-Jan 30-Jan 4-Feb 9-Feb 14-Feb 19-Feb 24-Feb
Dividend Yield
Earnings Yield
12M-1M Momentum
1M Reversal
EPS Growth
ROE
Low Volatility
3M Earnings Revisions
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
0.75
31-Dec 5-Jan 10-Jan 15-Jan 20-Jan 25-Jan 30-Jan 4-Feb 9-Feb 14-Feb 19-Feb 24-Feb
Dividend Yield
1M Reversal
Low Volatility
Earnings Yield
EPS Growth
3M Earnings Revisions
12M-1M Momentum
ROE
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
1.15
1.10
1.10
1.05
1.05
1.00
1.00
0.95
0.95
0.90
0.90
0.85
0.80
31-Dec 5-Jan 10-Jan 15-Jan 20-Jan 25-Jan 30-Jan 4-Feb 9-Feb 14-Feb 19-Feb 24-Feb
Dividend Yield
1M Reversal
Low Volatility
Earnings Yield
EPS Growth
3M Earnings Revisions
12M-1M Momentum
ROE
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
0.85
31-Dec 5-Jan 10-Jan 15-Jan 20-Jan 25-Jan 30-Jan 4-Feb 9-Feb 14-Feb 19-Feb 24-Feb
Dividend Yield
1M Reversal
Low Volatility
Earnings Yield
EPS Growth
3M Earnings Revisions
12M-1M Momentum
ROE
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Page 17
4 March 2014
The Quant View
1.10
1.10
1.05
1.05
1.00
0.95
1.00
0.90
0.95
0.85
0.80
0.90
0.75
0.70
0.85
0.65
0.80
31-Dec 5-Jan 10-Jan 15-Jan 20-Jan 25-Jan 30-Jan 4-Feb 9-Feb 14-Feb 19-Feb 24-Feb
Dividend Yield
Earnings Yield
12M-1M Momentum
1M Reversal
EPS Growth
ROE
Low Volatility
3M Earnings Revisions
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
0.60
31-Dec 5-Jan 10-Jan 15-Jan 20-Jan 25-Jan 30-Jan 4-Feb 9-Feb 14-Feb 19-Feb 24-Feb
Dividend Yield
1M Reversal
Low Volatility
Earnings Yield
EPS Growth
3M Earnings Revisions
12M-1M Momentum
ROE
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
1.08
1.04
1.06
1.02
1.04
1.00
1.02
0.98
1.00
0.96
0.98
0.94
0.96
0.94
0.92
0.92
0.90
0.90
0.88
0.88
31-Dec 5-Jan 10-Jan 15-Jan 20-Jan 25-Jan 30-Jan 4-Feb 9-Feb 14-Feb 19-Feb 24-Feb
0.86
31-Dec 5-Jan 10-Jan 15-Jan 20-Jan 25-Jan 30-Jan 4-Feb 9-Feb 14-Feb 19-Feb 24-Feb
Dividend Yield
1M Reversal
Low Volatility
Earnings Yield
EPS Growth
3M Earnings Revisions
12M-1M Momentum
ROE
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Page 18
Dividend Yield
1M Reversal
Low Volatility
Earnings Yield
EPS Growth
3M Earnings Revisions
12M-1M Momentum
ROE
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
4 March 2014
The Quant View
The QCD model is our flagship stock selection model for U.S. equities.
For complete details on the model, please see Luo et al., QCD Model: DB
Quant Handbook, 22 July 2010.
Name
DOW CHEMICAL
FERRO CORP
FEDERAL-MOGUL CORP
GENTEX CORP
VERIZON COMMUNICATIONS INC
ALON USA ENERGY INC
WORLD FUEL SERVICES CORP
AFFYMETRIX INC
MRC GLOBAL INC
AT&T INC
TEREX CORP
NRG YIELD INC
PERKINELMER INC
KIMBERLY-CLARK CORP
DYNEGY INC
COMVERSE INC
COLGATE-PALMOLIVE CO
TAKE-TWO INTERACTIVE SFTWR
E TRADE FINANCIAL CORP
PZENA INVESTMENT MANAGEMENT
GICS Sector
Materials
Materials
Consumer Discretionary
Consumer Discretionary
Telecommunication Services
Energy
Energy
Health Care
Industrials
Telecommunication Services
Industrials
Utilities
Health Care
Consumer Staples
Utilities
Information Technology
Consumer Staples
Information Technology
Financials
Financials
QCD Score
(higher is better long)
15.4%
14.4%
12.5%
12.3%
12.2%
11.8%
10.5%
10.4%
10.0%
9.9%
9.4%
9.3%
9.0%
8.7%
8.2%
7.7%
7.6%
7.0%
6.2%
5.5%
Ticker
BODY
UNXL
NSM
TWGP
ACFN
PSMI
WTSL
BIOL
FCSC
ACTG
KIOR
FWM
VLGEA
AMRS
MCP
ANV
NIHD
IRDM
WGL
SJW
Name
CUSIP
BODY CENTRAL CORP
09689U102
UNI-PIXEL INC
904572203
NATIONSTAR MORTGAGE HOLDINGS63861C109
TOWER GROUP INTL LTD
G8988C105
ACORN ENERGY INC
4848107
PEREGRINE SEMICONDUCTOR CORP71366R703
WET SEAL INC
961840105
BIOLASE INC
90911108
FIBROCELL SCIENCE INC
315721209
ACACIA RESEARCH CORP
3881307
KIOR INC
497217109
FAIRWAY GROUP HOLDINGS
30603D109
VILLAGE SUPER MARKET -CL A
927107409
AMYRIS INC
03236M101
MOLYCORP INC
608753109
ALLIED NEVADA GOLD CORP
19344100
NII HOLDINGS INC
62913F201
IRIDIUM COMMUNICATIONS INC 46269C102
WGL HOLDINGS INC
92924F106
SJW CORP
784305104
GICS Sector
Consumer Discretionary
Information Technology
Financials
Financials
Industrials
Information Technology
Consumer Discretionary
Health Care
Health Care
Industrials
Energy
Consumer Staples
Consumer Staples
Energy
Materials
Materials
Telecommunication Services
Telecommunication Services
Utilities
Utilities
QCD Score
(lower is better short)
-24.0%
-21.9%
-21.9%
-21.7%
-21.6%
-19.6%
-18.8%
-17.3%
-17.0%
-16.7%
-15.4%
-14.9%
-12.9%
-10.7%
-9.1%
-8.4%
-8.2%
-6.9%
-3.5%
-2.1%
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope, Deutsche Bank
Page 19
4 March 2014
The Quant View
0.8
0.6
0.4
0.2
0.0
(0.2)
(0.4)
(0.6)
(0.8)
(1.0)
(1.2)
Industrials
Health Care
Value
Materials
Growth
Energy
Momentum
Telecom.
Sentiment
Utilities
Quality
Info. Tech.
Technical
Cons. Staples
Industry
Tree
Financials
Cons. Discr.
QCD
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope, Deutsche Bank
Model performance
The QCD model has performed well since inception. Figure 42 shows the pure signal
performance, measured as a monthly sector-neutral rank information coefficient (IC).
Figure 43 shows the performance of an actual model portfolio, after costs, based on a
realistically optimized market-neutral strategy.
Figure 43: Model portfolio active return, after costs
40.0
8.0
30.0
6.0
20.0
Active Return
Sector-Neutral Rank IC
10.0
0.0
(10.0)
4.0
2.0
0.0
(20.0)
(2.0)
(30.0)
(4.0)
Sector-Neutral Rank IC
12M Avg
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Active Return
12M Avg
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Figure 44 shows the cumulative performance of the optimized strategy, and Figure 45
shows the annualized Sharpe ratio (after costs) by calendar year.
Page 20
4 March 2014
The Quant View
1400
7.0
1200
6.0
5.0
800
600
400
200
0
Sharpe Ratio
1000
4.0
3.0
2.0
1.0
0.0
(1.0)
(2.0)
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Page 21
4 March 2014
The Quant View
The N-LASR model is our flagship stock selection model for global equities.
For complete details on the model, please see Wang et al., Signal Processing:
The Rise of the Machines, 5 June 2012.
Name
Sands China Ltd.
Safran SA
PPG INDUSTRIES INC
Hanssem Co Ltd
PTT Global Chemical PCL
Tenaga Nasional Bhd
Amadeus Fire AG
SEAGATE TECHNOLOGY PLC
Jasmine International PCL
KDDI Corp
PENTAIR LTD
MTN Group Ltd
TE CONNECTIVITY LTD
Lupin Ltd
HORIZON NORTH LOGISTICS INC
Mediclinic International Ltd
WESTERN DIGITAL CORP
Oceana Group Ltd
Exedy Corp
Cairo Communication SpA
SEDOL
B5B23W
B058TZ
2698470
653668
B67QFW
690461
562366
B58JVZ5
B9GHRJ
624899
B8DTTS0
656320
B62B7C3
614376
B16TCX4
B0PGJF
2954699
665706
625041
410351
N-LASR Score
(higher is better long)
3.09
2.65
2.53
2.49
2.44
2.41
2.39
2.38
2.31
2.28
2.27
2.26
2.25
2.23
2.23
2.23
2.21
2.21
2.17
2.16
County
Hong Kong
France
USA
Korea
Thailand
Malaysia
Germany
USA
Thailand
Japan
USA
South Africa
USA
India
Canada
South Africa
USA
South Africa
Japan
Italy
Ticker
005690 KS
064260 KS
1903 TT
4100 JT
094190 KS
INL IB
8270 HK
049550 KS
276 HK
1919 JT
LIGO SP
VVUS
025560 KS
GARAN TI
MFRISCOA MM
SRPT
BTX
3436 JT
SOCOVESA CI
JOE
Name
Pharmicell Co Ltd
Danal Co
Shihlin Paper Corp
Toda Kogyo Corp
ELK Corp/Korea
Indian Infotech & Software Ltd
China Leason CBM Group Co Ltd
InkTec Co Ltd
Mongolia Energy Corporation Ltd.
Yamada SxL Home Co Ltd
Lion Gold Corp Ltd
VIVUS INC
Mirae Co
Turkiye Garanti Bankasi
Minera Frisco SAB de CV
SAREPTA THERAPEUTICS INC
BIOTIME INC
Sumco Corp
Socovesa SA
ST JOE CO
SEDOL
County
698839 Korea
B01RWL
Korea
680453
Taiwan
689350
Japan
B28VMK Korea
B7F28W
India
B6WVCM China
651112
Korea
B02L83
Hong Kong
649615
Japan
B6SZHB
Singapore
2934657
USA
610618
Korea
B03MYP
Turkey
B3QHKH Mexico
B8DPDT7 USA
2092221
USA
B0M0C8
Japan
B284N3
Chile
2768663
USA
N-LASR Score
(lower is better short)
-2.43
-2.37
-2.29
-2.25
-2.24
-2.23
-2.22
-2.21
-2.21
-2.21
-2.20
-2.17
-2.16
-2.16
-2.16
-2.16
-2.16
-2.15
-2.15
-2.13
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope, Deutsche Bank
Model performance
The N-LASR model has performed well since inception. Figure 47 shows the average
pure signal performance, measured as a monthly rank information coefficient (IC), in
different regions. Figure 48 shows the performance of a global model portfolio, after
costs, based on a realistically optimized market-neutral strategy.
Figure 48: Global portfolio active return, after costs
18.0
8.0
16.0
6.0
14.0
Active Return
12.0
10.0
8.0
6.0
4.0
2.0
0.0
(2.0)
(4.0)
2.0
(6.0)
0.0
US
EU ex Asia ex Japan
UK
Japan
EM
Canada
UK
Aus/NZ Global
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Page 22
4.0
Active Return
12M Avg
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
4 March 2014
The Quant View
Figure 49 shows the cumulative performance of the optimized strategy, and Figure 50
shows the annualized Sharpe ratio (after costs) by calendar year.
Figure 49: Global portfolio cumulative, after costs
1600
1400
1000
800
600
400
200
Sharpe Ratio
1200
8.0
6.0
4.0
2.0
0.0
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Page 23
4 March 2014
The Quant View
Our Composite Country Rotation Model (CCRM) uses three sets of inputs to
dynamically rotate between countries in the MSCI All Country World Index.
The inputs include top-down macro signals (e.g. VRP, Kellys Tail Risk),
aggregate bottom-up fundamental signals (e.g. country-level valuation and
momentum), and lead-lag signals based on economic trade linkages.
For complete details on the model, please see Luo et al., Signal Processing:
New Insights in Country Rotation, 9 February 2012.
Current recommendations
Figure 51 and Figure 52 show the top and bottom third of countries, as ranked currently
by our CCRM model. The bars show what is driving these calls.
Figure 51: Top tercile countries
5.0
4.0
3.0
2.0
1.0
0.0
(1.0)
(2.0)
(3.0)
(4.0)
2.0
1.0
0.0
(1.0)
(2.0)
(3.0)
(4.0)
(5.0)
(6.0)
Kelly
VRP
MCRM
Momentum
Valuation
Sentiment
CCRM
Kelly
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
VRP
MCRM
Momentum
Valuation
Sentiment
CCRM
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Model performance
Figure 53 and Figure 54 show the performance of the model over time.
Figure 53: Long/short quantile portfolio return
10
80
40
(%)
(%)
-5
-40
Avg = 1.06%
Std. Dev. = 3.19%
Min = -9.51%
Avg/Std. Dev.= 0.33
-10
03 04
05
06
-80
07
08
09
10
11
12
13
14
Page 24
Avg = 9.34%
Std. Dev. = 28.59%
Min = -61.36%
Avg/Std. Dev.= 0.33
03 04
05
06
07
08
09
10
11
12
13
14
4 March 2014
The Quant View
Our Quantitative Tactical Asset Allocation (QTAA) model uses a model-ofmodels methodology to rotate between six asset classes.
For complete details on the model, please see Luo et al., Signal Processing:
Quant Tactical Asset Allocation, 19 September 2011.
Crude Oil
100
(%)
-50
Gold
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
-100
Avg = 6.04%
Std. Dev. = 60.35%
Min = -95.54%
Avg/Std. Dev.= 0.1
05
06
07
08
09
10
11
12
13
14
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Page 25
4 March 2014
The Quant View
The model uses market-based and macroeconomic inputs to predict monthahead factor returns using a backwards stepwise linear regression model.
For complete details on the model, please see Luo et al., Signal Processing:
Style Rotation, 7 September 2010.
(4.0)
100
(%)
50
-50
-100
(2.0)
0.0
2.0
Forecast IC (%)
4.0
6.0
Avg = 12.79%
Std. Dev. = 45.19%
Min = -89.51%
Avg/Std. Dev.= 0.28
2000
2002
Style IC
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
Page 26
2004
2006
2008
2010
2012
2014
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope,
Deutsche Bank
4 March 2014
The Quant View
Avg # of
Hit
Serial
# of Stocks
Current
Last M
12M Avg
3Y Avg
Avg
Std Dev
Std Dev
Max
Min
p-value 2
Months
Stocks
Rate (%)
Corr (%)3
Ascending
Ascending
Descending
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Descending
Descending
Ascending
Descending
2,971
2,971
2,309
2,933
2,689
2,673
1,627
2,933
2,394
2,971
1,583
2,840
2,895
2,854
2,942
2,606
(6.29)
(6.84)
(0.56)
(4.97)
(2.85)
(2.24)
4.18
(4.27)
(3.03)
(2.92)
(2.76)
(1.77)
0.05
(4.30)
(3.69)
(1.15)
(2.56)
(2.38)
2.00
1.62
2.33
2.23
2.45
1.88
(0.06)
1.69
1.85
3.83
2.01
(2.52)
1.57
0.11
1.69
1.94
1.54
3.64
3.06
2.08
1.32
3.18
0.37
2.42
0.19
3.97
1.15
(1.09)
2.14
(0.65)
2.75
3.00
2.76
4.72
4.34
3.83
1.82
4.23
1.56
4.02
2.70
4.83
1.81
0.74
4.08
0.47
14.34
14.86
10.32
12.92
12.25
11.86
10.39
8.34
6.81
10.81
17.40
7.89
10.93
10.59
9.67
8.66
0.19
0.20
0.27
0.37
0.35
0.32
0.18
0.51
0.23
0.37
0.16
0.61
0.17
0.07
0.42
0.05
42.59
44.46
30.82
47.24
48.88
47.02
41.11
28.96
20.73
47.14
66.06
31.93
30.02
26.28
39.32
22.50
(33.26)
(33.89)
(32.28)
(33.30)
(34.61)
(34.31)
(26.63)
(14.90)
(18.74)
(32.67)
(54.29)
(22.64)
(41.46)
(35.75)
(27.15)
(33.21)
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.22
0.00
0.34
314
314
238
238
314
314
238
238
144
314
284
277
314
314
314
314
2,875
2,875
2,354
2,874
2,543
2,444
1,916
2,872
2,035
2,875
779
2,519
2,800
2,765
2,822
2,437
54.14
53.50
59.24
61.76
62.42
63.38
59.24
68.49
60.42
64.65
57.75
74.73
57.01
48.73
67.52
49.04
99.08
99.30
95.15
96.39
94.99
94.38
93.41
95.97
96.95
96.01
95.46
94.66
99.06
97.52
95.47
95.65
2. Growth
17 Hist 5Y operating EPS growth
18 Hist 5Y operating EPS acceleration
19 IBES 5Y EPS growth
20 IBES 5Y EPS growth/stability
21 IBES LTG EPS mean
22 IBES FY2 mean DPS growth
23 IBES FY1 mean EPS growth
24 Year-over-year quarterly EPS growth
25 IBES FY1 mean CFPS growth
26 IBES SUE, amortized
Descending
Ascending
Ascending
Ascending
Descending
Ascending
Ascending
Ascending
Descending
Ascending
2,841
2,841
2,391
2,391
1,882
2,110
2,627
2,949
1,118
2,526
5.11
(5.42)
4.95
1.96
(2.67)
(1.47)
2.64
3.23
(4.72)
2.88
1.60
(0.13)
2.89
3.01
(2.53)
0.04
1.98
1.75
(1.88)
2.01
3.07
0.59
2.51
2.64
(0.55)
1.59
1.35
2.60
(1.00)
1.77
1.10
0.79
0.98
1.39
1.57
0.84
1.08
2.52
0.35
0.82
8.59
6.59
8.04
7.64
15.69
8.46
7.41
6.95
11.05
6.41
0.13
0.12
0.12
0.18
0.10
0.10
0.15
0.36
0.03
0.13
30.58
25.31
21.65
20.64
37.64
24.12
20.76
23.85
38.08
20.62
(22.70)
(16.13)
(27.86)
(19.20)
(52.38)
(21.96)
(24.42)
(21.12)
(42.07)
(16.30)
0.06
0.07
0.03
0.00
0.08
0.24
0.01
0.00
0.62
0.04
226
226
314
314
314
141
314
238
241
253
2,736
2,736
2,300
2,300
2,145
1,520
2,521
2,879
550
1,128
53.54
53.98
54.78
57.32
49.36
50.35
61.78
66.39
50.21
54.55
97.33
94.84
98.25
98.60
97.70
87.33
88.93
81.54
92.74
73.90
Descending
Descending
Descending
Descending
Ascending
Ascending
Ascending
Ascending
2,971
2,971
2,968
2,971
2,826
2,826
2,861
2,452
(0.90)
(2.69)
(7.50)
3.89
4.92
4.97
(1.64)
9.09
2.17
0.17
(0.06)
0.82
2.77
2.95
1.35
2.27
2.97
0.45
3.43
1.71
3.11
3.52
3.50
2.47
4.95
1.85
4.98
0.26
3.23
4.07
3.08
1.17
7.13
10.80
14.83
6.56
13.95
13.06
17.61
10.86
0.69
0.17
0.34
0.04
0.23
0.31
0.17
0.11
15.52
29.03
39.13
24.16
39.62
37.65
49.63
25.63
(33.75)
(43.69)
(56.07)
(16.78)
(57.00)
(49.06)
(62.50)
(35.41)
0.00
0.00
0.00
0.48
0.00
0.00
0.00
0.06
314
314
314
314
314
314
314
302
2,876
2,875
2,750
2,865
2,793
2,793
1,964
2,240
77.71
58.28
63.69
51.27
64.97
65.61
61.46
56.62
1.57
0.52
53.90
56.06
89.96
88.49
83.24
97.43
4. Sentiment
35 IBES LTG Mean EPS Revision, 3M
36 IBES FY1 Mean EPS Revision, 3M
37 IBES FY1 EPS up/down ratio, 3M
38 Expectation gap, short-term - long-term
39 IBES FY1 Mean CFPS Revision, 3M
40 IBES FY1 Mean SAL Revision, 3M
41 IBES FY1 Mean FFO Revision, 3M
42 IBES FY1 Mean DPS Revision, 3M
43 IBES FY1 Mean ROE Revision, 3M
44 Recommendation, mean
45 Mean recommendation revision, 3M
46 Target price implied return
47 Mean target price revision, 3M
Ascending
Ascending
Ascending
Descending
Ascending
Ascending
Ascending
Ascending
Ascending
Descending
Descending
Ascending
Ascending
1,862
2,663
2,462
2,138
1,523
2,617
142
1,296
2,122
2,699
2,696
2,657
2,652
0.12
0.25
0.85
2.39
1.10
(1.61)
(10.32)
0.44
1.68
3.52
(1.43)
3.84
0.64
0.33
0.99
1.39
0.07
2.57
1.32
(2.53)
1.70
1.58
3.13
0.85
2.17
2.64
0.84
1.74
1.95
1.70
2.23
1.80
0.26
1.52
0.93
2.22
0.40
0.11
2.11
0.85
2.88
3.04
1.18
2.02
1.08
2.68
0.78
0.73
0.91
1.22
0.26
2.39
3.73
8.37
7.79
5.18
15.79
7.74
20.89
5.15
6.48
7.48
4.06
16.55
12.44
0.23
0.34
0.39
0.23
0.13
0.14
0.13
0.15
0.11
0.12
0.30
0.02
0.19
11.16
29.96
27.54
9.60
69.38
27.43
71.43
14.91
23.70
21.85
19.86
60.74
30.14
(12.06)
(33.00)
(24.41)
(19.91)
(75.04)
(24.32)
(80.00)
(17.55)
(22.19)
(19.41)
(11.55)
(39.59)
(41.94)
0.00
0.00
0.00
0.00
0.03
0.04
0.03
0.08
0.19
0.06
0.00
0.84
0.01
314
314
314
314
283
213
286
138
138
243
240
179
176
2,117
2,482
2,346
2,124
711
2,186
85
1,012
1,734
2,679
2,666
2,470
2,457
61.78
66.88
67.52
57.96
62.54
60.09
56.99
58.70
59.42
57.61
62.92
54.19
63.64
59.65
75.18
79.45
91.10
64.26
71.40
69.24
62.85
66.38
94.43
60.10
80.07
74.99
5. Quality
48 ROE, trailing 12M
49 Return on invested capital (ROIC)
50 Sales to total assets (asset turnover)
51 Operating profit margin
52 Current ratio
53 Long-term debt/equity
54 Altman's z-score
55 Merton's distance to default
56 Ohlson default model
57 Accruals (Sloan 1996 def)
58 Firm-specific discretionary accruals
59 Hist 5Y operating EPS stability, coef of determination
60 IBES 5Y EPS stability
61 IBES FY1 EPS dispersion
62 Payout on trailing operating EPS
63 YoY change in # of shares outstanding
64 YoY change in debt outstanding
65 Net external financing/net operating assets
66 Piotroski's F-score
67 Mohanram's G-score
Ascending
Ascending
Ascending
Ascending
Descending
Ascending
Ascending
Ascending
Descending
Descending
Descending
Ascending
Descending
Descending
Ascending
Descending
Descending
Ascending
Ascending
Ascending
2,834
2,922
2,890
2,881
2,279
2,829
2,175
2,258
2,208
2,138
1,186
2,841
2,391
2,689
2,228
2,872
2,177
2,956
2,971
536
(1.20)
(2.02)
2.09
(2.44)
0.55
2.85
(1.51)
(2.62)
(0.98)
1.55
1.48
5.28
(6.13)
1.56
(6.45)
0.23
(1.07)
3.22
(0.16)
(0.45)
1.75
1.49
2.60
(0.23)
0.46
0.48
0.85
1.22
(0.78)
(0.30)
(1.07)
2.03
0.62
0.82
(4.07)
1.37
(0.56)
0.44
1.59
0.11
3.20
3.36
1.67
0.33
0.86
1.76
1.79
2.99
1.03
(0.39)
(0.41)
1.17
1.57
2.79
(0.21)
3.00
(0.18)
2.23
2.55
1.47
3.79
4.09
1.62
1.15
1.78
0.79
0.31
3.27
2.24
0.51
0.44
0.88
1.14
1.51
0.65
2.56
0.25
2.40
2.89
2.55
10.03
10.21
8.66
5.44
10.14
9.54
9.10
11.67
6.33
4.15
3.27
4.99
8.54
9.01
13.45
8.85
4.07
8.43
8.04
10.44
0.38
0.40
0.19
0.21
0.18
0.08
0.03
0.28
0.35
0.12
0.13
0.18
0.13
0.17
0.05
0.29
0.06
0.29
0.36
0.24
33.42
33.02
22.78
16.98
31.95
35.65
31.74
33.03
16.95
12.07
9.42
20.01
25.00
31.67
38.55
19.53
13.07
44.61
29.20
35.27
(29.52)
(31.24)
(22.02)
(14.17)
(38.66)
(28.14)
(30.44)
(41.45)
(18.63)
(15.48)
(10.87)
(12.27)
(34.33)
(25.17)
(30.91)
(46.21)
(10.40)
(21.76)
(27.83)
(32.14)
0.00
0.00
0.00
0.00
0.00
0.14
0.55
0.00
0.00
0.03
0.03
0.01
0.02
0.00
0.40
0.00
0.28
0.00
0.00
0.00
238
238
314
314
314
314
314
314
277
314
254
226
314
314
314
314
314
314
314
226
2,862
2,857
2,815
2,722
2,240
2,749
2,160
2,336
2,127
2,139
2,108
2,736
2,300
2,543
2,212
2,771
2,220
2,838
2,878
389
64.71
68.49
56.37
59.55
54.14
48.73
49.04
65.29
67.51
54.78
55.51
53.10
53.50
59.55
49.04
60.83
55.41
61.15
67.52
56.19
96.34
98.04
99.45
98.44
97.89
98.41
98.35
95.02
98.29
88.58
78.52
96.93
98.96
84.21
98.94
94.19
90.00
94.76
88.31
95.49
6. Technicals
68 # of days to cover short
69 CAPM beta, 5Y monthly
70 CAPM idosyncratic vol, 1Y daily
71 Realized vol, 1Y daily
72 Skewness, 1Y daily
73 Kurtosis, 1Y daily
74 Idiosyncratic vol surprise
75 Normalized abnormal volume
76 Float turnover, 12M
77 Moving average crossover, 15W-36W
78 Log float-adj capitalization
79 # of month in the database
80 DB composite options factor
Descending
Descending
Descending
Descending
Descending
Descending
Descending
Ascending
Descending
Ascending
Ascending
Ascending
Ascending
319
2,970
2,970
2,869
2,869
2,869
2,919
2,971
2,971
2,871
2,957
2,971
1,969
1.35
(6.92)
(4.36)
(7.11)
(5.15)
(4.37)
(4.50)
6.14
(12.99)
2.14
10.06
(1.34)
1.56
(0.26)
(1.24)
0.18
0.42
(0.98)
(0.21)
1.98
1.41
(1.64)
2.28
1.88
(0.30)
(0.47)
1.35
0.24
4.71
4.65
(0.04)
0.66
1.49
2.72
(0.12)
1.30
3.52
1.62
0.90
2.14
0.93
5.05
4.89
1.18
1.38
2.85
2.25
0.16
2.19
3.46
2.14
1.39
7.28
13.65
17.96
18.58
5.33
5.50
7.93
6.36
10.70
13.05
10.91
8.77
3.61
0.29
0.07
0.28
0.26
0.22
0.25
0.36
0.35
0.01
0.17
0.32
0.24
0.38
33.80
40.19
42.60
42.69
13.93
15.28
22.66
23.10
23.53
46.29
29.53
35.61
13.99
(25.16)
(42.70)
(60.80)
(59.63)
(22.86)
(15.82)
(33.71)
(16.38)
(26.97)
(55.07)
(40.68)
(23.86)
(13.88)
0.00
0.28
0.00
0.00
0.00
0.00
0.00
0.00
0.80
0.00
0.00
0.00
0.00
314
255
302
314
314
314
301
314
303
314
314
314
151
2,033
2,910
2,882
2,793
2,793
2,793
2,863
2,868
2,789
2,536
2,872
2,875
2,023
58.60
50.59
61.26
60.51
56.37
61.78
66.78
65.61
47.85
60.51
61.46
56.69
66.23
91.43
97.67
99.16
99.14
89.76
91.51
87.80
64.23
99.76
90.80
99.42
99.99
23.96
Factor Name
1. Value
1 Dividend yield, trailing 12M
2 Expected dividend yield
3 Price-to-operating EPS, trailing 12M, Basic
4 Operating earnings yield, trailing 12M, Basic
5 Earnings yield, forecast FY1 mean
6 Earnings yield, forecast FY2 mean
7 Earnings yield x IBES 5Y growth
8 Sector-rel Operating earnings yield, trailing 12M, Basic
9 Hist-rel Operating earnings yield, trailing 12M, Basic
10 Operating cash flow yield (income stmt def)
11 Cash flow yield, FY1 mean
12 Free cash flow yield
13 Price-to-sales, trailing 12M
14 Price-to-book
15 EBITDA/EV
16 Price-to-book adj for ROE, sector adj
Direction1
Average IC (%)
Avg /
Note:
1 Direction indicates how the factor scores are sorted. Ascending order means higher factors scores are likely to be associated with higher subsequent stock returns, and vice versa for descending order.
2 P-value indicates the statistical significance of the factor's performance. A smaller p-value suggests that is it more likely the factor's performance is different from zero.
3 This is the autocorrelation of the factor scores over time. Higher serial correlation indicates lower portfolio turnover based on the factor.
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope, Deutsche Bank
Page 27
4 March 2014
The Quant View
Figure 60: Global factor performance, measured as rank IC (S&P BMI World universe)
Since Inception
Current
# of
Avg # of
Hit
Serial
# of Stocks
Last M
12M Avg
3Y Avg
Avg
Std Dev
Std Dev
Max
Min
p-value 2
Months
Stocks
Rate (%)
Corr (%)3
Ascending
Ascending
Ascending
Descending
Descending
Ascending
Ascending
Ascending
Ascending
Ascending
Descending
Descending
Ascending
Ascending
Ascending
10,152
7,859
7,844
8,434
7,792
8,904
8,518
8,471
6,911
5,986
9,608
9,685
7,446
7,792
9,475
(1.60)
0.54
1.00
(5.34)
(2.67)
(2.15)
(5.84)
(5.96)
(3.86)
(6.72)
(10.24)
(13.25)
(10.81)
2.99
(9.75)
(1.00)
(1.40)
(1.74)
(2.55)
(1.95)
(0.69)
(0.78)
(1.48)
1.31
(0.42)
0.78
(3.39)
(3.75)
7.15
2.84
2.74
2.15
1.78
(0.51)
(1.01)
1.24
1.02
(0.32)
0.52
(1.30)
(0.35)
(2.29)
(3.01)
5.83
1.27
4.14
4.16
4.05
3.90
2.82
3.91
4.59
4.21
3.91
1.95
1.46
1.08
0.99
4.02
1.97
10.48
10.80
10.86
13.01
10.20
9.13
10.82
11.81
6.32
9.64
9.51
10.43
9.79
10.81
7.85
0.40
0.39
0.37
0.30
0.28
0.43
0.42
0.36
0.62
0.20
0.15
0.10
0.10
0.37
0.25
36.88
32.17
33.19
39.66
28.98
31.67
35.35
37.31
26.42
31.42
26.48
31.56
30.37
36.69
24.81
(23.89)
(22.90)
(24.39)
(50.73)
(37.08)
(18.68)
(22.20)
(31.50)
(11.80)
(32.01)
(31.59)
(37.54)
(26.29)
(26.20)
(20.06)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.08
0.19
0.00
0.00
290
233
223
283
290
290
290
290
166
222
290
290
174
290
290
8,051
5,307
5,269
6,342
6,063
7,047
6,498
6,326
5,024
4,515
7,529
7,578
5,470
4,731
7,494
63.79
63.09
63.23
61.13
61.72
63.79
63.10
62.07
74.70
57.66
55.86
56.21
52.30
62.76
61.38
97.99
98.19
98.17
96.34
96.41
96.33
95.69
95.73
97.16
96.01
99.24
98.35
98.10
95.60
99.00
2. Growth
16 IBES 5Y EPS growth
17 EPS Growth
18 IBES LTG EPS mean
19 IBES FY1 mean EPS growth
20 IBES FY1 mean CFPS growth
21 IBES FY2 mean DPS growth
22 Asset growth
Ascending
Ascending
Descending
Ascending
Descending
Ascending
Descending
8,370
9,180
4,858
7,913
5,211
7,823
9,539
2.70
0.46
(0.98)
(1.89)
0.82
1.50
0.37
0.14
1.04
(1.62)
1.01
1.78
(1.08)
4.04
1.64
1.66
0.10
(0.02)
1.32
(0.25)
1.84
1.07
2.03
1.29
0.38
1.74
2.38
0.70
6.09
6.80
11.99
6.01
4.17
10.89
8.44
0.18
0.30
0.11
0.06
0.42
0.22
0.08
19.09
29.72
28.22
14.44
7.47
38.85
21.57
(21.86)
(28.97)
(40.36)
(20.10)
(11.39)
(31.49)
(27.36)
0.00
0.00
0.07
0.28
0.00
0.00
0.16
290
274
290
290
166
232
290
6,255
6,931
4,183
6,398
3,956
5,151
7,324
58.97
64.23
52.76
54.83
65.66
59.05
53.10
98.06
88.48
96.73
88.58
91.79
88.13
93.73
Descending
Descending
Ascending
Ascending
Ascending
Ascending
10,163
10,163
10,158
9,849
9,849
8,723
(1.47)
(8.02)
5.55
3.65
2.82
11.04
2.21
(1.20)
3.19
7.92
7.54
1.93
3.93
2.09
1.10
6.25
6.55
2.05
3.58
2.89
0.17
4.47
5.07
1.44
7.37
8.68
11.34
14.39
13.87
13.95
0.49
0.33
0.01
0.31
0.37
0.10
21.94
30.60
27.69
41.64
40.96
40.32
(41.58)
(33.64)
(44.07)
(46.50)
(42.52)
(44.84)
0.00
0.00
0.80
0.00
0.00
0.08
290
290
290
290
290
290
8,162
8,161
8,156
7,963
7,963
6,468
71.03
63.79
53.45
67.24
69.31
58.28
2.00
1.39
4.13
90.69
88.82
97.73
4. Sentiment
29 IBES LTG Mean EPS Revision, 1M
30 IBES LTG Mean EPS Revision, 3M
31 IBES FY1 EPS up/down ratio, 1M
32 IBES FY1 EPS up/down ratio, 3M
33 IBES FY1 Mean EPS Revision, 1M
34 IBES FY1 Mean EPS Revision, 3M
35 IBES FY1 Mean CFPS Revision, 3M
36 IBES FY1 Mean DPS Revision, 1M
37 IBES FY1 Mean DPS Revision, 3M
38 IBES FY1 Mean FFO Revision, 1M
39 IBES FY1 Mean FFO Revision, 3M
40 IBES FY1 Mean ROE Revision, 1M
41 IBES FY1 Mean ROE Revision, 3M
42 Target price implied return
43 Recommendation, mean
44 Mean recommendation revision, 3M
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Descending
Descending
Descending
4,840
4,788
4,296
7,674
8,373
8,239
5,698
6,188
6,136
7,653
7,484
8,350
8,220
8,492
8,705
8,645
(0.70)
(1.24)
0.71
(0.23)
(1.54)
(1.81)
(2.03)
(2.26)
(0.57)
(2.54)
(0.92)
(2.83)
(3.54)
5.90
0.38
(0.23)
1.29
1.67
3.90
4.04
2.86
3.60
2.08
1.91
3.75
3.14
4.54
1.76
2.38
3.21
2.67
1.90
0.58
0.94
3.58
4.00
2.83
3.76
2.42
2.62
3.77
3.03
4.19
1.93
2.22
2.26
2.33
1.52
0.68
0.87
3.67
3.64
2.86
3.36
2.45
1.74
2.22
2.22
2.84
1.75
2.16
0.97
1.80
1.90
2.55
3.30
5.38
5.76
5.04
6.59
5.50
4.34
5.79
4.02
5.72
4.05
4.98
14.38
6.75
2.90
0.27
0.26
0.68
0.63
0.57
0.51
0.45
0.40
0.38
0.55
0.50
0.43
0.43
0.07
0.27
0.65
7.26
11.05
17.76
17.92
16.50
19.37
15.81
12.65
19.08
11.73
16.27
13.70
13.57
55.58
17.41
10.01
(8.59)
(10.26)
(13.76)
(12.36)
(12.79)
(20.12)
(23.83)
(16.63)
(24.51)
(8.89)
(14.53)
(10.51)
(13.58)
(36.25)
(16.84)
(10.13)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.37
0.00
0.00
290
290
290
290
290
290
212
231
229
158
155
210
208
174
243
240
4,145
4,090
4,372
5,869
6,349
6,257
4,335
4,386
4,326
4,175
4,081
5,452
5,323
6,356
7,228
7,206
63.45
62.07
76.90
75.17
72.07
73.45
76.42
71.86
72.49
77.22
74.19
69.05
69.23
53.45
65.84
75.42
0.63
60.16
34.67
78.46
24.05
74.15
63.87
10.89
65.68
13.49
67.90
14.46
68.63
82.35
94.49
60.11
5. Quality
45 Return on Equity
46 return on capital
47 Return on Assets
48 Asset Turnover
49 Gross margin
50 EBITDA margin
51 Berry Ratio
52 IBES FY1 EPS dispersion
53 IBES 5Y EPS growth/stability
54 YoY change in debt outstanding
55 Current ratio
56 Long-term debt/equity
57 Merton's distance to default
58 Capex to Dep
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Ascending
Descending
Ascending
Descending
Descending
Ascending
Ascending
Descending
9,432
9,426
9,652
9,623
8,907
9,763
7,469
8,518
8,370
7,897
7,938
9,507
8,079
7,730
6.50
5.74
5.81
4.99
5.88
2.00
6.71
(2.43)
4.24
(2.12)
(0.45)
4.67
0.81
1.27
1.26
0.66
5.11
8.74
2.18
4.79
(2.45)
4.83
0.32
1.52
(1.38)
0.81
3.90
6.71
3.58
3.15
5.48
5.13
2.59
4.13
(0.13)
4.21
2.04
0.60
0.18
1.12
4.28
3.72
4.13
4.37
4.73
2.73
1.84
3.97
2.76
0.50
1.41
0.27
0.57
0.79
2.63
1.59
10.08
12.20
13.19
16.21
5.81
13.70
9.28
9.49
5.95
3.89
8.82
6.42
11.04
6.49
0.41
0.36
0.36
0.17
0.32
0.29
0.30
0.05
0.24
0.07
0.06
0.12
0.24
0.24
30.68
49.47
44.20
44.64
16.60
42.97
29.57
32.68
18.66
11.51
27.86
22.37
31.19
22.38
(34.69)
(34.02)
(30.31)
(51.55)
(13.45)
(41.30)
(20.79)
(25.37)
(20.47)
(11.34)
(27.01)
(18.17)
(31.18)
(19.93)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.37
0.00
0.23
0.27
0.04
0.00
0.00
242
290
290
290
290
290
290
290
290
290
290
290
290
290
7,714
7,014
7,117
7,590
6,904
7,610
5,349
6,498
6,254
6,319
6,188
7,502
6,499
5,186
66.53
64.83
63.79
57.93
62.76
59.66
58.97
50.69
58.62
53.79
48.97
54.48
60.34
61.72
97.16
97.98
98.16
99.85
98.90
96.80
97.73
87.94
98.30
91.57
98.52
98.90
93.26
96.95
6. Technicals
59 Realized vol, 1Y daily
60 Skewness, 1Y daily
61 Moving average crossover, 15W-36W
62 Normalized abnormal volume
Descending
Descending
Ascending
Ascending
9,853
9,853
9,654
10,107
6.54
1.67
5.03
(0.31)
5.10
0.76
6.05
3.99
5.51
1.86
3.75
2.93
5.08
1.61
3.06
2.28
15.22
5.29
14.47
6.50
0.33
0.30
0.21
0.35
29.45
15.03
37.15
20.47
(44.64)
(32.98)
(45.46)
(14.71)
0.00
0.00
0.00
0.00
290
290
290
290
7,970
7,970
6,980
7,929
61.38
63.79
63.10
61.03
98.97
90.04
91.38
66.31
Factor Name
1. Value
1 Dividend yield, trailing 12M
2 Dividend yield, FY1
3 Dividend yield, FY2
4 Price/Earnings
5 Price-to-FY0 EPS
6 Earnings yield, FY0
7 Earnings yield, forecast FY1 mean
8 Earnings yield, forecast FY2 mean
9 Cash flow yield, FY0
10 Cash flow yield, FY1 mean
11 Price/Sales
12 Price/Book
13 Est Book-to-price, median
14 EBITDA to EV
15 Sales/EV
Direction
Average IC (%)
Avg /
Note:
1 Direction indicates how the factor scores are sorted. Ascending order means higher factors scores are likely to be associated with higher subsequent stock returns, and vice versa for descending order.
2 P-value indicates the statistical significance of the factor's performance. A smaller p-value suggests that is it more likely the factor's performance is different from zero.
3 This is the autocorrelation of the factor scores over time. Higher serial correlation indicates lower portfolio turnover based on the factor.
Source: Bloomberg Finance LP, Compustat, IBES, MSCI, Russell, S&P, Thomson Reuters, Worldscope, Deutsche Bank
Page 28
4 March 2014
The Quant View
Appendix 1
Important Disclosures
Additional information available upon request
For disclosures pertaining to recommendations or estimates made on securities other than the primary subject of this
research, please see the most recently published company report or visit our global disclosure look-up page on our
website at http://gm.db.com/ger/disclosure/DisclosureDirectory.eqsr
Analyst Certification
The views expressed in this report accurately reflect the personal views of the undersigned lead analyst(s). In addition,
the undersigned lead analyst(s) has not and will not receive any compensation for providing a specific recommendation
or view in this report. Sheng Wang/Miguel-A Alvarez/Javed Jussa/Zongye Chen/Allen Wang/Yin Luo
Hypothetical Disclaimer
Backtested, hypothetical or simulated performance results have inherent limitations. Unlike an actual performance
record based on trading actual client portfolios, simulated results are achieved by means of the retroactive application of
a backtested model itself designed with the benefit of hindsight. Taking into account historical events the backtesting of
performance also differs from actual account performance because an actual investment strategy may be adjusted any
time, for any reason, including a response to material, economic or market factors. The backtested performance
includes hypothetical results that do not reflect the reinvestment of dividends and other earnings or the deduction of
advisory fees, brokerage or other commissions, and any other expenses that a client would have paid or actually paid.
No representation is made that any trading strategy or account will or is likely to achieve profits or losses similar to
those shown. Alternative modeling techniques or assumptions might produce significantly different results and prove to
be more appropriate. Past hypothetical backtest results are neither an indicator nor guarantee of future returns. Actual
results will vary, perhaps materially, from the analysis.
Page 29
4 March 2014
The Quant View
Regulatory Disclosures
1.Important Additional Conflict Disclosures
Aside from within this report, important conflict disclosures can also be found at https://gm.db.com/equities under the
"Disclosures Lookup" and "Legal" tabs. Investors are strongly encouraged to review this information before investing.
3. Country-Specific Disclosures
Australia and New Zealand: This research, and any access to it, is intended only for "wholesale clients" within the
meaning of the Australian Corporations Act and New Zealand Financial Advisors Act respectively.
Brazil: The views expressed above accurately reflect personal views of the authors about the subject company(ies) and
its(their) securities, including in relation to Deutsche Bank. The compensation of the equity research analyst(s) is
indirectly affected by revenues deriving from the business and financial transactions of Deutsche Bank. In cases where
at least one Brazil based analyst (identified by a phone number starting with +55 country code) has taken part in the
preparation of this research report, the Brazil based analyst whose name appears first assumes primary responsibility for
its content from a Brazilian regulatory perspective and for its compliance with CVM Instruction # 483.
EU
countries:
Disclosures
relating
to
our
obligations
under
MiFiD
can
be
found
at
http://www.globalmarkets.db.com/riskdisclosures.
Japan: Disclosures under the Financial Instruments and Exchange Law: Company name - Deutsche Securities Inc.
Registration number - Registered as a financial instruments dealer by the Head of the Kanto Local Finance Bureau
(Kinsho) No. 117. Member of associations: JSDA, Type II Financial Instruments Firms Association, The Financial Futures
Association of Japan, Japan Investment Advisers Association. Commissions and risks involved in stock transactions - for
stock transactions, we charge stock commissions and consumption tax by multiplying the transaction amount by the
commission rate agreed with each customer. Stock transactions can lead to losses as a result of share price fluctuations
and other factors. Transactions in foreign stocks can lead to additional losses stemming from foreign exchange
fluctuations. "Moody's", "Standard & Poor's", and "Fitch" mentioned in this report are not registered credit rating
agencies in Japan unless Japan or "Nippon" is specifically designated in the name of the entity. Reports on Japanese
listed companies not written by analysts of Deutsche Securities Inc. (DSI) are written by Deutsche Bank Group's analysts
with the coverage companies specified by DSI.
Russia: This information, interpretation and opinions submitted herein are not in the context of, and do not constitute,
any appraisal or evaluation activity requiring a license in the Russian Federation.
Page 30
David Folkerts-Landau
Group Chief Economist
Member of the Group Executive Committee
Guy Ashton
Global Chief Operating Officer
Research
Michael Spencer
Regional Head
Asia Pacific Research
Marcel Cassard
Global Head
FICC Research & Global Macro Economics
Ralf Hoffmann
Regional Head
Deutsche Bank Research, Germany
Andreas Neubauer
Regional Head
Equity Research, Germany
Steve Pollard
Regional Head
Americas Research
International Locations
Deutsche Bank AG
Deutsche Bank Place
Level 16
Corner of Hunter & Phillip Streets
Sydney, NSW 2000
Australia
Tel: (61) 2 8258 1234
Deutsche Bank AG
Groe Gallusstrae 10-14
60272 Frankfurt am Main
Germany
Tel: (49) 69 910 00
Deutsche Bank AG
Filiale Hongkong
International Commerce Centre,
1 Austin Road West,Kowloon,
Hong Kong
Tel: (852) 2203 8888
Global Disclaimer
The information and opinions in this report were prepared by Deutsche Bank AG or one of its affiliates (collectively "Deutsche Bank"). The information herein is believed to be reliable and has been obtained from public
sources believed to be reliable. Deutsche Bank makes no representation as to the accuracy or completeness of such information.
Deutsche Bank may engage in securities transactions, on a proprietary basis or otherwise, in a manner inconsistent with the view taken in this research report. In addition, others within Deutsche Bank, including
strategists and sales staff, may take a view that is inconsistent with that taken in this research report.
Deutsche Bank may be an issuer, advisor, manager, distributor or administrator of, or provide other services to, an ETF included in this report, for which it receives compensation.
Opinions, estimates and projections in this report constitute the current judgement of the author as of the date of this report. They do not necessarily reflect the opinions of Deutsche Bank and are subject to change
without notice. Deutsche Bank has no obligation to update, modify or amend this report or to otherwise notify a recipient thereof in the event that any opinion, forecast or estimate set forth herein, changes or
subsequently becomes inaccurate. Prices and availability of financial instruments are subject to change without notice. This report is provided for informational purposes only. It is not an offer or a solicitation of an
offer to buy or sell any financial instruments or to participate in any particular trading strategy. Target prices are inherently imprecise and a product of the analyst judgement.
As a result of Deutsche Banks March 2010 acquisition of BHF-Bank AG, a security may be covered by more than one analyst within the Deutsche Bank group. Each of these analysts may use differing methodologies
to value the security; as a result, the recommendations may differ and the price targets and estimates of each may vary widely.
In August 2009, Deutsche Bank instituted a new policy whereby analysts may choose not to set or maintain a target price of certain issuers under coverage with a Hold rating. In particular, this will typically occur for
"Hold" rated stocks having a market cap smaller than most other companies in its sector or region. We believe that such policy will allow us to make best use of our resources. Please visit our website at
http://gm.db.com to determine the target price of any stock.
The financial instruments discussed in this report may not be suitable for all investors and investors must make their own informed investment decisions. Stock transactions can lead to losses as a result of price
fluctuations and other factors. If a financial instrument is denominated in a currency other than an investor's currency, a change in exchange rates may adversely affect the investment.
All prices are those current at the end of the previous trading session unless otherwise indicated. Prices are sourced from local exchanges via Reuters, Bloomberg and other vendors. Data is sourced from Deutsche
Bank and subject companies.
Past performance is not necessarily indicative of future results. Deutsche Bank may with respect to securities covered by this report, sell to or buy from customers on a principal basis, and consider this report in
deciding to trade on a proprietary basis.
Derivative transactions involve numerous risks including, among others, market, counterparty default and illiquidity risk. The appropriateness or otherwise of these products for use by investors is dependent on the
investors' own circumstances including their tax position, their regulatory environment and the nature of their other assets and liabilities and as such investors should take expert legal and financial advice before
entering into any transaction similar to or inspired by the contents of this publication. Trading in options involves risk and is not suitable for all investors. Prior to buying or selling an option investors must review the
"Characteristics and Risks of Standardized Options," at http://www.theocc.com/components/docs/riskstoc.pdf If you are unable to access the website please contact Deutsche Bank AG at +1 (212) 250-7994, for a copy
of this important document.
The risk of loss in futures trading and options, foreign or domestic, can be substantial. As a result of the high degree of leverage obtainable in futures and options trading, losses may be incurred that are greater than
the amount of funds initially deposited.
Unless governing law provides otherwise, all transactions should be executed through the Deutsche Bank entity in the investor's home jurisdiction. In the U.S. this report is approved and/or distributed by Deutsche
Bank Securities Inc., a member of the NYSE, the NASD, NFA and SIPC. In Germany this report is approved and/or communicated by Deutsche Bank AG Frankfurt authorized by the BaFin. In the United Kingdom this
report is approved and/or communicated by Deutsche Bank AG London, a member of the London Stock Exchange and regulated by the Financial Conduct Authority for the conduct of investment business in the UK
and authorized by the BaFin. This report is distributed in Hong Kong by Deutsche Bank AG, Hong Kong Branch, in Korea by Deutsche Securities Korea Co. This report is distributed in Singapore by Deutsche Bank AG,
Singapore Branch or Deutsche Securities Asia Limited, Singapore Branch (One Raffles Quay #18-00 South Tower Singapore 048583, +65 6423 8001), and recipients in Singapore of this report are to contact Deutsche
Bank AG, Singapore Branch or Deutsche Securities Asia Limited, Singapore Branch in respect of any matters arising from, or in connection with, this report. Where this report is issued or promulgated in Singapore to a
person who is not an accredited investor, expert investor or institutional investor (as defined in the applicable Singapore laws and regulations), Deutsche Bank AG, Singapore Branch or Deutsche Securities Asia
Limited, Singapore Branch accepts legal responsibility to such person for the contents of this report. In Japan this report is approved and/or distributed by Deutsche Securities Inc. The information contained in this
report does not constitute the provision of investment advice. In Australia, retail clients should obtain a copy of a Product Disclosure Statement (PDS) relating to any financial product referred to in this report and
consider the PDS before making any decision about whether to acquire the product. Deutsche Bank AG Johannesburg is incorporated in the Federal Republic of Germany (Branch Register Number in South Africa:
1998/003298/10). Additional information relative to securities, other financial products or issuers discussed in this report is available upon request. This report may not be reproduced, distributed or published by any
person for any purpose without Deutsche Bank's prior written consent. Please cite source when quoting.
Copyright 2014 Deutsche Bank AG